ENTITY
J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals (JBCP IN)

37
Analysis
Health Care • India
J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.
more
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
bullish•Corona Remedies
•08 Dec 2025 21:21

Corona Remedies IPO Review: Rolling up Growth

CRL focuses on chronic therapies for Women's healthcare and cardio-diabetics, with a diverse portfolio of 550+ products. It follows a roll-up...

Logo
397 Views
Share
bullish•Corona Remedies
•08 Dec 2025 08:30

Corona Remedies IPO: Well-Positioned for Multi-Year Profitable Growth

Corona Remedies IPO will open for subscription on December 8 and close on December 10. The IPO price band has been set at INR1,008–1,062 per share....

Logo
539 Views
Share
•02 Jul 2025 22:39

Event Driven: Torrent Acquires JB Chemicals ~ The Second-Largest Pharma Deal in Indian History

​Torrent Pharmaceuticals acquires JB Chemicals in ₹25,689 crore deal, boosting market share, expanding presence in CDMO sector, and driving revenue...

Logo
498 Views
Share
•09 Jul 2024 14:14

Emcure Pharma Pre-IPO Trading - Strong Subscription, Will Pop

Emcure Pharmaceuticals raised around US$240m in its India IPO. Subscription rates were strong for institutional and HNI tranche.

Logo
444 Views
Share
x